Silencing HIFAL leads to 90% reduction in HIF-1 binding to its target genes, and thus dramatically decreases the efficiency of HIF-1 transactivation and suppresses glycolysis in the tumor cells under hypoxia. This evidence concerns the gene ENSG00000258667 and neoplasm.